Peripheral arterial disease is prevalent but underdiagnosed and undertreated in the primary care setting in central Greece

Angiology

Volumn 64, Issue 2, 2013, Pages 119-124

  Argyriou, Christos ^a   Saleptsis, Vasileios ^a   Koutsias, Stylianos ^a   Giannoukas, Athanasios D ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

ankle brachial index; atherosclerosis; peripheral arterial disease; risk factors

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GREECE; GROUPS BY AGE; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICIAN; PREVALENCE; PRIMARY HEALTH CARE; SMOKING;

AGED; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; PRIMARY HEALTH CARE; QUESTIONNAIRES; RISK FACTORS;

EID: 84872570586     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712439092     Document Type: Article

References (32)

1. Hirsch AT, Hiatt WR. PAD awareness, risk, and treatment: new resources for survival - the USA PARTNERS program. Vasc Med. 2001 ; 6 (3 suppl). 9-12
2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 ; 113 (11). e463 - e654
3. TransAtlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg. 2000 ; 19 ((suppl A:Si-xxviii)). S1 - S250
4. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001 ; 286 (11). 1317-1324
5. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006 ; 295 (2). 180-189
6. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis. 1981 ; 34 (6). 261-269
7. Leng GC, Papacosta O, Whincup P, et al. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis. 2000 ; 152 (1). 167-174
8. McDermott MM, Hahn EA, Greenland R, et al. Atheroslerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. J Gen Intern Med. 2002 ; 17 (12). 895-904
9. McDermott MM, Mandapat AL, Moates A, et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med. 2003 ; 163 (18). 2157-2162
10. Taylor-Piliae RE, Fair JM, Varady AN, et al. Ankle brachial index screening in asymptomatic older adults. Am Heart J. 2011 ; 161 (5). 979-985
11. Campbell NC, McNiff C, Sheran J, Brittenden J, Lee AJ, Ritchie LD. Targeted screening for peripheral arterial disease in general practice: a pilot study in a high risk group. Br J Gen Pract. 2007 ; 57 (537). 311-315
12. Cacoub P, Cambou JP, Kownator S, et al. Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int J Clin Pract. 2009 ; 63 (1). 63-70
13. Ramos R, Quesada M, Solanas P, et al. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg. 2009 ; 38 (3). 305-311
14. Doubeni CA, Yood RA, Emani S, Gurwitz JH. Identifying unrecognized peripheral arterial disease among asymptomatic patients in the primary care setting. Angiology. 2006 ; 57 (2). 171-180
15. Santo Signorelli S, Anzaldi M, Fiore V, et al. Study on unrecognized peripheral arterial disease (PAD) by ankle/brachial index and arterial comorbidity in Catania, Sicily, Italy. Angiology. 2010 ; 61 (6). 524-529
16. Kroger K, Stang A, Kondratieva J, et al. Prevalence of peripheral arterial disease-results of the Heinz Nixdorf recall study. Eur J Epidemiol. 2006 ; 21 (4). 279-285
17. Hayoz D, Bounameaux H, Canova CR. Swiss atherothrombosis survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease. J Intern Med. 2005 ; 258 (3). 238-243
18. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004 ; 172 (1). 95-105
19. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004 ; 110 (6). 738-743
20. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam study. Arterioscler Thromb Vasc Biol. 1998 ; 18 (2). 185-192
21. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002 ; 143 (6). 961-965
22. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol. 1996 ; 25 (2). 282-290
23. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993 ; 88 (3). 837-845
24. Hirsch AT, Halverson SL, Treat-Jacobson D, et al. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med. 2001 ; 6 (2). 87-96
25. Hooi JD, Stoffers HE, Kester AD, et al. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care. 1998 ; 16 (3). 177-182
26. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991 ; 20 (2). 384-392
27. Sritara P, Sritara C, Woodward M, et al. Prevalence and risk factors of peripheral arterial disease in a selected Thai population. Angiology. 2007 ; 58 (5). 572-578
28. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA. 2006 ; 295 (5). 547-553
29. Duprez DA. Pharmacological interventions for peripheral artery disease. Expert Opin Pharmacother. 2007 ; 8 (10). 1465-1477
30. Paraskevas KI, Giannoukas AD, Mikhailidis DP. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected. Ann Vasc Surg. 2009 ; 23 (5). 690-699
31. Bianchi C, Montalvo V, Ou HW, et al. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation. Ann Vasc Surg. 2007 ; 21 (2). 163-166
32. Brevetti G, Oliva G, Giuglian G, et al. Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners. J Gen Intern Med. 2007 ; 22 (5). 639-644